ConMed acquires MedShape’s ExoShape ACL portfolio

MedShape deals ExoShape ACL portfolio to ConMed (MassDevice)
MedShape said today it inked a deal to divest its ExoShape ACL fixation system properties to ConMed (NSDQ:CNMD) for an undisclosed amount.
The deal, which closed on Monday, includes Atlanta-based MedShape’s ExoShape femoral and tibial soft tissue fasteners designed to fixate soft tissue grafts in anterior cruciate ligament reconstructive surgery.
“The ExoShape system has represented a valuable portion of MedShape’s business since 2011, and this acquisition further demonstrates the success of the development and commercialization effo...